Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) ad hoc meeting, 28 June – 1 July 2024

Philipp Lambach; Sheetal Silal; Alyssa N. Sbarra; Natasha S. Crowcroft; Kurt Frey; Matt Ferrari; Emilia Vynnycky; C. Jessica E. Metcalf; Amy K. Winter; Laura Zimmerman; Mitsuki Koh; Meru Sheel; Sun Young Kim; Patrick K. Munywoki; Allison Portnoy; Rakesh Aggarwal; Habib Hasan Farooqui; Stefan Flasche; Alexandra B. Hogan; Kathy Leung; William J. Moss; Xuan Yi Wang

doi:10.1016/j.vaccine.2024.126307

Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) ad hoc meeting, 28 June – 1 July 2024

Philipp Lambach, Sheetal Silal, Alyssa N. Sbarra, Natasha S. Crowcroft, Kurt Frey, Matt Ferrari, Emilia Vynnycky, C. Jessica E. Metcalf, Amy K. Winter, Laura Zimmerman, Mitsuki Koh, Meru Sheel, Sun Young Kim, Patrick K. Munywoki, Allison Portnoy, Rakesh Aggarwal, Habib Hasan Farooqui, Stefan Flasche, Alexandra B. Hogan, Kathy LeungWilliam J. Moss, Xuan Yi Wang

Research output: Contribution to journal › Article › peer-review

Abstract

The World Health Organization's Immunization and Vaccines-related Implementation Research Advisory Committee (IVIR-AC) serves to independently review and evaluate vaccine-related research to maximize the potential impact of vaccination programs. From 28 June – 1 July 2024, IVIR-AC was convened for an ad hoc meeting to discuss new evidence on criteria for rubella vaccine introduction and the risk of congenital rubella syndrome. This report summarizes background information on rubella virus transmission and the burden of congenital rubella syndrome, meeting structure and presentations, proceedings, and recommendations.

Original language	English (US)
Article number	126307
Journal	Vaccine
Volume	42
Issue number	26
DOIs	https://doi.org/10.1016/j.vaccine.2024.126307
State	Published - Dec 2 2024

All Science Journal Classification (ASJC) codes

Molecular Medicine
General Immunology and Microbiology
General Veterinary
Public Health, Environmental and Occupational Health
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.vaccine.2024.126307

Cite this

Lambach, P., Silal, S., Sbarra, A. N., Crowcroft, N. S., Frey, K., Ferrari, M., Vynnycky, E., Metcalf, C. J. E., Winter, A. K., Zimmerman, L., Koh, M., Sheel, M., Kim, S. Y., Munywoki, P. K., Portnoy, A., Aggarwal, R., Farooqui, H. H., Flasche, S., Hogan, A. B., ... Wang, X. Y. (2024). Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) ad hoc meeting, 28 June – 1 July 2024. Vaccine, 42(26), Article 126307. https://doi.org/10.1016/j.vaccine.2024.126307

@article{9d38936df2894e62973743932a811658,

title = "Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) ad hoc meeting, 28 June – 1 July 2024",

abstract = "The World Health Organization's Immunization and Vaccines-related Implementation Research Advisory Committee (IVIR-AC) serves to independently review and evaluate vaccine-related research to maximize the potential impact of vaccination programs. From 28 June – 1 July 2024, IVIR-AC was convened for an ad hoc meeting to discuss new evidence on criteria for rubella vaccine introduction and the risk of congenital rubella syndrome. This report summarizes background information on rubella virus transmission and the burden of congenital rubella syndrome, meeting structure and presentations, proceedings, and recommendations.",

author = "Philipp Lambach and Sheetal Silal and Sbarra, {Alyssa N.} and Crowcroft, {Natasha S.} and Kurt Frey and Matt Ferrari and Emilia Vynnycky and Metcalf, {C. Jessica E.} and Winter, {Amy K.} and Laura Zimmerman and Mitsuki Koh and Meru Sheel and Kim, {Sun Young} and Munywoki, {Patrick K.} and Allison Portnoy and Rakesh Aggarwal and Farooqui, {Habib Hasan} and Stefan Flasche and Hogan, {Alexandra B.} and Kathy Leung and Moss, {William J.} and Wang, {Xuan Yi}",

note = "Publisher Copyright: {\textcopyright} 2024",

year = "2024",

month = dec,

day = "2",

doi = "10.1016/j.vaccine.2024.126307",

language = "English (US)",

volume = "42",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier Ltd",

number = "26",

}

Lambach, P, Silal, S, Sbarra, AN, Crowcroft, NS, Frey, K, Ferrari, M, Vynnycky, E, Metcalf, CJE, Winter, AK, Zimmerman, L, Koh, M, Sheel, M, Kim, SY, Munywoki, PK, Portnoy, A, Aggarwal, R, Farooqui, HH, Flasche, S, Hogan, AB, Leung, K, Moss, WJ & Wang, XY 2024, 'Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) ad hoc meeting, 28 June – 1 July 2024', Vaccine, vol. 42, no. 26, 126307. https://doi.org/10.1016/j.vaccine.2024.126307

TY - JOUR

T1 - Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) ad hoc meeting, 28 June – 1 July 2024

AU - Lambach, Philipp

AU - Silal, Sheetal

AU - Sbarra, Alyssa N.

AU - Crowcroft, Natasha S.

AU - Frey, Kurt

AU - Ferrari, Matt

AU - Vynnycky, Emilia

AU - Metcalf, C. Jessica E.

AU - Winter, Amy K.

AU - Zimmerman, Laura

AU - Koh, Mitsuki

AU - Sheel, Meru

AU - Kim, Sun Young

AU - Munywoki, Patrick K.

AU - Portnoy, Allison

AU - Aggarwal, Rakesh

AU - Farooqui, Habib Hasan

AU - Flasche, Stefan

AU - Hogan, Alexandra B.

AU - Leung, Kathy

AU - Moss, William J.

AU - Wang, Xuan Yi

PY - 2024/12/2

Y1 - 2024/12/2

N2 - The World Health Organization's Immunization and Vaccines-related Implementation Research Advisory Committee (IVIR-AC) serves to independently review and evaluate vaccine-related research to maximize the potential impact of vaccination programs. From 28 June – 1 July 2024, IVIR-AC was convened for an ad hoc meeting to discuss new evidence on criteria for rubella vaccine introduction and the risk of congenital rubella syndrome. This report summarizes background information on rubella virus transmission and the burden of congenital rubella syndrome, meeting structure and presentations, proceedings, and recommendations.

AB - The World Health Organization's Immunization and Vaccines-related Implementation Research Advisory Committee (IVIR-AC) serves to independently review and evaluate vaccine-related research to maximize the potential impact of vaccination programs. From 28 June – 1 July 2024, IVIR-AC was convened for an ad hoc meeting to discuss new evidence on criteria for rubella vaccine introduction and the risk of congenital rubella syndrome. This report summarizes background information on rubella virus transmission and the burden of congenital rubella syndrome, meeting structure and presentations, proceedings, and recommendations.

UR - http://www.scopus.com/inward/record.url?scp=85203624733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85203624733&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2024.126307

DO - 10.1016/j.vaccine.2024.126307

M3 - Article

C2 - 39276622

AN - SCOPUS:85203624733

SN - 0264-410X

VL - 42

JO - Vaccine

JF - Vaccine

IS - 26

M1 - 126307

ER -

Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) ad hoc meeting, 28 June – 1 July 2024

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this